SCHEMBL25307235

SCHEMBL25307235

CC1CC(C)(C)CC2(COC(C)OC2)C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25254481 0.79 ESR1 (0.33) ESR1ESR2
SCHEMBL30694 0.74 MEN1 (0.36)
SCHEMBL17453557 0.73 ESR1 (0.33) ESR1ESR2
SCHEMBL4413629 0.71 ESR1 (0.45) ESR1ESR2
SCHEMBL25300064 0.71
SCHEMBL25444 0.71 ESR1 (0.35) ESR1ESR2
SCHEMBL1937905 0.69
SCHEMBL10265810 0.66
SCHEMBL27360264 0.66 MEN1 (0.32)
SCHEMBL910279 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154123-A1 COOLING COMPOUNDS AND COMPOSITIONS V MANE FILS (FR) 2025-05-15 US claimed
EP-4460283-A1 COOLING COMPOUNDS AND COMPOSITIONS V. Mane Fils (FR) 2024-11-13 EP claimed
CN-118742286-A Cooling compound and composition 玛奈·菲尔萨公司 2024-10-01 CN claimed
WO-2023131667-A1 COOLING COMPOUNDS AND COMPOSITIONS V. MANE FILS (FR) 2023-07-13 WO claimed
US-20250154123-A1 COOLING COMPOUNDS AND COMPOSITIONS V MANE FILS (FR) 2025-05-15 US disclosed
EP-4460283-A1 COOLING COMPOUNDS AND COMPOSITIONS V. Mane Fils (FR) 2024-11-13 EP disclosed
CN-118742286-A Cooling compound and composition 玛奈·菲尔萨公司 2024-10-01 CN disclosed
WO-2023131667-A1 COOLING COMPOUNDS AND COMPOSITIONS V. MANE FILS (FR) 2023-07-13 WO disclosed
WO-2023131667-A1 COOLING COMPOUNDS AND COMPOSITIONS V. MANE FILS (FR) 2023-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154123-A1 COOLING COMPOUNDS AND COMPOSITIONS CBR3, DECR1, DECR2 ESR1 812/4885ESR2 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.